INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX

File: 123096_sep96_decls12_0006.txt
Page: 0006
Total Pages: 32

Subject: INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX             

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: CAUTIONARY NOTE                                                                                 

Document Number:          2

Folder Seq  #:         14










                                                          2


                                                AM
                                   PRM=Cff, D          IS, AND

             2.1 Vaccination - Will be given to SM                        PriOritizaticn-
             U.S. Forces wiill          to be vaccinated as vaocine stocks are shiPPOd to
             the Ar-R. @cELl laboratory              , health care             and the NBc
             teams tasked with the BW detection mlssicn should reoelve highest priority
             for         and botulmm vaccimtlcn.                       will           1Y
             hand:Le and        EW samples and/or care for BW @ents.        @ BW            04
             are rxyt      ious nor pose a hazard to other St4. Medical                    d
             exercim care 3n the management and handlug of blood samples and Other bOdY
             fluids of         tic          p&Uents.

                  a. Anthrax

                       (1)              VaoCirle (0.5 Ml doses) is given at day 0, 14, arid
             28 with 3 additional doses given at six         intervals. For Operation
             Desert Sh3.eld the modified series is given at day 0 and 14. Significant
             levels of           arxi a protective level agairist anthrax can be expected two
             weeks after the second vaccimtion.

                       (2) After all U.S. Forces have been vaccinated with two doses, each
             St4 will receive a thixd vaccination dose to increase protection.

                  b.       irmm        - Botulin= vaccine (tcxdid)         d be given in 0. 5
             Ml doses deep              ly at day 0, 14, and 84 (Week 12) With proteCtiVe
             l@s of antibodies establi@ two               foll@ the thixd dose. Booster
             dose is given one year.

             2.2 D@is

                  a. Anthrax

                       (1) Signs and              fl-ver, fatigue, and shortness of breath
 (2)                   c (WM) k:Lts         d be positioned at medical
             treatmer-rt facilities throughout the AcR.        is a refrigeration
                         for        kits, but stability          has        the kit to be
             stable for six weeks at         tures of 450 C   (li3o F). @ intent of
             us@ this kit is to provide a prel                      c test to eroble medical
                       to support           ve cluucal          is of anthrax. Confirmation
             by alternative laboratory tests is esserrtial.   See para loe. Indicators for
             use of SMW kits are as follows:







                                                     2-1

Document 32 f:/Week-36/BX003201/CAUTIONARY NOTE/interim medical doctrine bw defense against anth:12179609280113
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = CAUTIONARY NOTE
Folder Seq # = 14
Subject = INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTH
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996